Table 2.
Drug-related adverse events occurring in >20% of patients and all grade ≥3 drug-related events grouped by preferred term according to CTC AE 4.0
| Adverse event | Grade 1 n (%) |
Grade 2 n (%) |
Grade 3 n (%) |
|---|---|---|---|
| Fatigue | 9 (38) | 0 (0) | 1 (4) |
| Myalgia | 9 (42) | 0 (0) | 0 (0) |
| Dyspnea | 5 (21) | 2 (8) | 0 (0) |
| Neuropathy | 4 (21) | 1 (4) | 1 (4) |
| Headache | 6 (25) | 0 (0) | 0 (0) |
| Constipation | 5 (21) | 0 (0) | 0 (0) |
| Nausea | 5 (21) | 0 (0) | 0 (0) |
| Neutrophil count decreased | 3 (13) | 0 (0) | 1 (4) |
| Pneumonitis | 0 (0) | 0 (0) | 1 (4) |
| Urinary tract infection | 1 (4) | 0 (0) | 1 (4) |